VECO Stock Cash Flow Statements

Veeco Instruments Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Veeco Instruments Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-09-30	2004-06-30	2004-03-31	2003-03-31	2001-09-30

cash flows from operating activities
net income	11,733,000	11,947,000	14,965,000	21,951,000	14,944,000	21,854,000	21,637,000	24,574,000	-85,320,000	8,741,000	128,916,000	15,041,000	9,655,000	13,330,000	8,203,000	8,993,000	6,348,000	2,494,000	-101,000	579,000	-8,302,000	-567,000	-32,871,000	-11,767,000	-15,565,000	-18,530,000	-144,674,000	-8,953,000	-237,634,000	-15,827,000	-5,616,000	-21,884,000	-18,388,000	1,095,000	-4,998,000	-69,597,000	-32,082,000	-15,533,000	-9,787,000	5,305,000	-8,386,000	-19,110,000	-56,912,000	-13,977,000	-15,211,000	19,160,000	-22,085,000	-6,026,000	-4,081,000	-10,071,000	11,753,000	11,818,000	16,412,000	35,863,000	19,206,000	52,642,000	86,163,000	52,393,000	26,044,000				-1,673,000	4,202,000	-1,583,000	-5,683,000	-2,595,000	293,000	7,626,000	4,508,000	3,025,000	-242,000	2,688,000	1,566,000	-449,000	-4,702,000	-1,455,000	1,581,000	-704,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	5,101,000	5,035,000	5,982,000	6,153,000	6,603,000	6,405,000	6,349,000	6,182,000	6,159,000	6,276,000	6,545,000	6,351,000	6,509,000	6,240,000	6,424,000	6,445,000	6,367,000	6,822,000	7,676,000	7,649,000	7,648,000	7,724,000	8,561,000	8,523,000	8,519,000	8,796,000	8,888,000	8,804,000	14,580,000	17,726,000	17,800,000	16,675,000	9,821,000	5,799,000	6,640,000	8,719,000	8,698,000	8,593,000	9,084,000	9,041,000	11,001,000	10,724,000	6,924,000	6,049,000	5,829,000	5,771,000	6,345,000	4,095,000	4,058,000	3,927,000	4,347,000	4,119,000	3,715,000	2,282,000	3,743,000	3,266,000	70,000	4,896,000	4,986,000	5,204,000	5,310,000	5,556,000	6,635,000	5,909,000	5,594,000	5,829,000	6,065,000	7,394,000	7,654,000	7,832,000	7,279,000	7,315,000	7,408,000	7,323,000	7,345,000	7,735,000	7,779,000	7,834,000	8,083,000
non-cash interest expense	293,000	257,000	322,000	322,000	317,000	296,000	294,000	310,000	288,000	226,000	243,000	242,000	239,000	238,000	3,057,000	3,662,000	3,586,000	3,514,000	3,510,000	3,504,000	3,458,000	3,320,000	3,258,000	3,199,000	3,138,000	3,081,000	3,023,000	2,968,000	2,912,000	2,859,000	2,805,000	2,754,000	2,702,000	2,185,000
deferred income taxes	-900,000	1,567,000	-10,614,000	1,952,000	775,000	-842,000	-183,000	-2,806,000	587,000	191,000	-117,997,000	-25,000	-2,000	-16,000	-639,000	-29,000	21,000	-4,000	-629,000	139,000	76,000	115,000	340,000	10,000	25,000	-15,000	1,252,000								-589,000	-292,000	1,356,000	465,000	854,000	915,000	272,000	607,000									-309,000	-87,000	674,000	51,000	-1,239,000	7,988,000			152,000	323,000	138,000	222,000	298,000	320,000	642,000	664,000			1,079,000	-12,000	148,000	155,000				52,000
share-based compensation expense	9,651,000	9,208,000	9,105,000	9,459,000	9,233,000	8,082,000	6,179,000	7,420,000	7,932,000	7,027,000	6,025,000	6,210,000	6,278,000	4,481,000	3,514,000	4,130,000	4,368,000	3,237,000	3,141,000	2,942,000	2,974,000	3,646,000	3,742,000	3,783,000	4,588,000	3,157,000	3,354,000	3,279,000	4,904,000	4,537,000	4,420,000	6,170,000	9,620,000	4,186,000	3,608,000	3,743,000	4,002,000	4,388,000	3,948,000	5,119,000	4,921,000	3,998,000
changes in contingent consideration
changes in operating assets and liabilities:
accounts receivable and contract assets	4,943,000	-14,011,000	29,199,000	-31,309,000	9,035,000	-13,480,000	24,654,000	-1,238,000	-13,302,000	3,157,000	32,122,000	-28,602,000	-19,167,000	2,821,000	-13,677,000	8,171,000	-14,347,000	-6,811,000	316,000	-21,223,000	18,392,000	-27,846,000	22,104,000	-22,535,000	14,361,000	-8,134,000	21,052,000
inventories	-4,933,000	-7,316,000	-4,612,000	2,985,000	-1,842,000	-4,838,000	13,960,000	-4,578,000	-18,777,000	-25,763,000	-19,171,000	-12,244,000	2,381,000	-8,254,000																														1,598,000	3,902,000	8,150,000	588,000				17,383,000	12,289,000	10,599,000							4,477,000	10,103,000	4,960,000											10,564,000	1,202,000	3,603,000	5,372,000
prepaid expenses and other current assets	3,094,000	-2,434,000	-4,331,000	740,000	-1,555,000	395,000	-4,709,000	-5,721,000	-850,000	-4,783,000	-720,000	157,000	16,471,000	-8,240,000	-2,208,000	5,340,000	4,825,000	-336,000	-1,628,000	2,596,000	-2,098,000	-1,480,000	8,796,000	2,681,000	-1,500,000	-2,457,000	1,179,000	5,169,000	1,044,000	3,824,000					3,065,000	1,257,000			-371,000
accounts payable and accrued expenses	-20,357,000	21,874,000	-12,661,000	9,377,000	-14,675,000	17,621,000	-18,048,000	139,000	-4,332,000	13,431,000	-7,043,000	11,541,000	-32,386,000	14,773,000	-1,561,000	7,740,000	1,434,000	12,612,000	4,829,000	5,310,000	-8,639,000	14,459,000	-10,945,000	9,955,000	-13,695,000	-12,260,000	-15,666,000	-15,767,000	9,752,000	2,009,000	9,032,000			642,000					9,102,000	-18,673,000	7,884,000	11,157,000
contract liabilities	465,000	-7,776,000	-15,482,000	-88,000	-13,255,000	-24,215,000
income taxes receivable and payable	173,000	2,475,000	4,801,000			853,000	1,428,000	-84,000	-1,963,000	94,000	853,000	-33,000	-35,000	-228,000	124,000	374,000	277,000	172,000	25,000	-32,000	-31,000	124,000	-62,000	-6,000	-124,000	-463,000	-1,248,000							130,000	467,000				-1,564,000	14,000	-291,000	2,600,000
other	-221,000	-834,000	-357,000	-344,000	-766,000	-2,145,000	-739,000	-334,000	-300,000	-213,000	-1,602,000	842,000	771,000	886,000	6,338,000	1,541,000	3,527,000	-2,413,000	-1,008,000	995,000	1,395,000	905,000	1,394,000	-95,000	-791,000	-100,000	288,000						-66,000	343,000	-237,000	1,780,000	323,000	86,000	-2,089,000	749,000	1,232,000	628,000					1,951,000	-6,000					14,000	-160,000	90,000	180,000				8,000				1,090,000	7,000										80,000	3,000	-913,000	-370,000	1,318,000		11,000
net cash from operating activities	9,042,000	19,992,000	28,385,000	17,614,000	8,455,000	9,361,000	29,485,000	7,054,000	11,217,000	13,918,000	33,109,000	47,205,000	3,381,000	24,788,000	17,093,000	29,920,000	10,244,000	10,485,000	15,430,000	10,041,000	19,946,000	-2,396,000	15,589,000	-14,864,000	14,150,000	-22,291,000	1,640,000				18,870,000			6,332,000					-6,061,000	9,889,000	7,673,000	4,288,000					-3,883,000	-9,141,000	3,265,000	10,486,000	45,284,000	18,641,000	41,910,000	-15,217,000	425,000	74,887,000	78,871,000	67,295,000	41,705,000	12,427,000	5,912,000	2,132,000	11,965,000	10,129,000	326,000	2,138,000	16,865,000	3,774,000	23,491,000	5,781,000	4,589,000	12,154,000	15,451,000	5,365,000	9,710,000	14,384,000	-1,554,000	2,678,000	3,807,000	-4,633,000	13,428,000

cash flows from investing activities
capital expenditures	-3,595,000	-6,755,000	-5,179,000	-3,991,000	-2,953,000	-5,990,000	-10,699,000	-6,395,000	-3,890,000	-6,946,000	-2,833,000	-6,351,000	-4,502,000	-10,918,000	-9,190,000	-22,371,000	-7,129,000	-1,953,000	-3,471,000	-1,374,000	-887,000	-1,070,000	-2,684,000	-1,748,000	-4,261,000	-2,180,000	-6,866,000
free cash flows	5,447,000	13,237,000	23,206,000	13,623,000	5,502,000	3,371,000	18,786,000	659,000	7,327,000	6,972,000	30,276,000	40,854,000	-1,121,000	13,870,000	7,903,000	7,549,000	3,115,000	8,532,000	11,959,000	8,667,000	19,059,000	-3,466,000	12,905,000	-16,612,000	9,889,000	-24,471,000	-5,226,000
proceeds from the sale of investments	38,274,000	66,200,000	37,513,000	35,015,000	28,222,000	53,473,000	52,040,000	17,918,000	72,846,000	40,049,000	15,146,000	21,257,000	21,075,000	2,260,000	131,227,000	69,077,000	75,013,000	55,385,000	33,999,000	35,901,000	32,500,000	71,130,000	25,119,000	61,730,000	18,000,000	22,500,000	24,700,000	20,000,000	11,365,000	34,000,000	41,170,000	72,171,000	208,175,000	27,411,000	21,004,000
payments for purchases of investments	-25,144,000	-44,922,000	-78,051,000	-60,635,000	-35,213,000	-28,791,000	-67,491,000	-41,069,000	-65,828,000	-3,492,000	-60,032,000	-10,106,000	-31,378,000	-2,498,000	-22,144,000	-69,092,000	-103,983,000	-52,037,000	-62,447,000	-85,311,000	-65,399,000	-34,866,000	-44,324,000	-72,556,000	-34,850,000	-41,258,000	-20,743,000
proceeds from sale of productive assets			0	0	0	2,033,000
net cash from investing activities	9,535,000	14,523,000	-45,717,000	-29,611,000	-9,944,000	20,725,000	-26,150,000	-29,546,000	3,128,000	-762,000	-47,719,000	4,800,000	-14,805,000	-11,156,000	101,618,000	-22,386,000	-36,099,000	1,395,000	-31,919,000	-50,784,000	-24,283,000	35,194,000	-21,889,000	-11,929,000	-21,111,000	-20,938,000	-2,909,000								4,043,000	9,447,000	26,491,000	6,729,000	-49,642,000	11,277,000	3,165,000	28,122,000	-44,510,000	21,569,000	16,925,000	14,119,000					19,823,000	21,065,000	16,336,000
cash flows from financing activities
restricted stock tax withholdings	-72,000	-6,675,000	-1,189,000	-287,000	-248,000	-14,340,000	-1,962,000	-246,000	-292,000	-8,509,000	-430,000	-703,000	-328,000	-6,787,000	-4,732,000	-1,513,000	-1,122,000	-1,625,000	-105,000	-699,000	-838,000	-680,000			-1,599,000	-642,000	-40,000
repayment of convertible debt
debt issuance costs
contingent consideration payments
proceeds (net of tax withholdings) from option exercises and employee stock purchase plan	1,480,000	1,399,000	935,000	1,182,000	1,868,000	1,318,000	912,000	1,087,000	1,378,000	1,241,000	789,000	780,000	1,131,000	998,000	693,000	844,000	987,000	878,000	450,000	836,000	636,000	956,000					57,000				446,000
net cash from financing activities	-4,706,000	-5,276,000	-254,000	895,000	1,620,000	-14,840,000	-1,050,000	-1,659,000	25,470,000	-27,441,000	359,000	77,000	803,000	-5,789,000	-120,478,000	-669,000	-135,000	-747,000	-1,506,000	137,000	30,191,000	276,000	288,000	295,000	-836,000	379,000	17,000			117,000	-3,368,000	-1,467,000	-5,012,000	335,787,000									2,346,000	228,000	-959,000	8,076,000				114,000	4,291,000	1,215,000	473,000				2,895,000	3,650,000	26,460,000														222,000	691,000	825,000	40,000	59,000	752,000	1,956,000		20,281,000
effect of exchange rate changes on cash and cash equivalents	51,000	9,000	-81,000	135,000	-2,000	-42,000	38,000	-13,000	-51,000	10,000	55,000	-57,000	-48,000	-3,000	8,000	-21,000	-9,000	-30,000	26,000	8,000	19,000	-48,000	17,000	-4,000	2,000	11,000				32,000	17,000	1,000	9,000	15,000	-40,000	-7,000	-12,000	39,000							59,000	89,000				60,000				331,000	937,000	792,000							-65,000	-27,000	127,000
net increase in cash, cash equivalents, and restricted cash	13,922,000	29,248,000	-17,667,000	-10,967,000	129,000	15,204,000	2,323,000	-24,164,000	39,764,000	-14,275,000	-14,196,000	52,025,000	-10,669,000	7,840,000	-1,759,000	6,844,000	-25,999,000	11,103,000	-17,969,000	-40,598,000	25,873,000	33,026,000	-5,995,000	-26,502,000	-7,795,000	-42,839,000	-1,252,000
cash, cash equivalents, and restricted cash - beginning of period	0	145,819,000	0	0	0	159,120,000	0	0	0	155,472,000	0	0	0	120,472,000	0	0	0	130,283,000	0	0	0	129,951,000	0	0	0	213,082,000	0	0	0	280,583,000
cash, cash equivalents, and restricted cash - end of period	13,922,000	175,067,000	-17,667,000	-10,967,000	129,000	174,324,000	2,323,000	-24,164,000	39,764,000	141,197,000	-14,196,000	52,025,000	-10,669,000	128,312,000	-1,759,000	6,844,000	-25,999,000	141,386,000	-17,969,000	-40,598,000	25,873,000	162,977,000	-5,995,000	-26,502,000	-7,795,000	170,243,000	-1,252,000	17,067,000	-49,099,000	246,366,000
supplemental disclosure of cash flow information
interest paid	3,910,000	712,000	4,021,000	801,000	4,060,000	619,000	4,485,000	668,000	3,884,000	2,744,000	2,379,000	2,723,000	2,444,000	2,593,000	3,512,000	4,879,000	2,357,000	1,803,000	3,711,000	3,481,000	827,000	4,681,000	7,000	4,680,000	28,000	4,693,000	53,000	4,963,000	18,000	4,674,000	8,000	4,602,000	34,000	31,000	46,000	76,000	64,000	39,000	381,000	33,000	35,000	36,000
net income taxes paid	1,265,000	-1,671,000													-9,000	66,000
non-cash activities
capital expenditures included in accounts payable and accrued expenses	-1,622,000	2,455,000	4,114,000	-309,000	-9,000	599,000	-3,991,000	4,441,000	-1,114,000	5,052,000	-4,424,000	245,000	211,000	6,253,000	-37,000	-6,267,000
right-of-use assets obtained in exchange for lease obligations	763,000	127,000	484,000	0			0	0	0	630,000	2,563,000	117,000	0	258,000	3,424,000	0	0	20,353,000	790,000	38,000			5,060,000	177,000	101,000	238,000
loss on extinguishment of debt							0	0											4,795,000	0																																		0	3,045,000	304,000
asset impairment																			0	0							122,829,000	0			0	1,000	675,000	463,000	-142,000	56,035,000			0	0	0	126,000
impairment of equity investments
benefit from bad debts							-174,000	0											0												0	7,000	0	92,000		0	0	160,000
acquisition of businesses, net of cash acquired							0	0	0	-30,373,000
proceeds from issuance of 2029 notes, net of issuance costs							0	0
extinguishment of convertible notes							0	0
income taxes paid, net of refunds received			68,000	435,000	1,539,000	992,000
net transfer of inventory to property, plant and equipment							0	-32,000	24,000	4,304,000	0	998,000	191,000	46,000									842,000	379,000			309,000					0	-48,000	81,000
change in contingent consideration				-4,644,000	494,000	-625,000	-466,000
contingent consideration payment				0	0	-1,818,000	0
proceeds from held for sale assets, net of costs to sell																			0	0
income taxes paid							1,234,000	878,000	2,597,000	386,000	85,000	266,000	560,000	523,000				240,000	81,000	182,000	-227,000	293,000	96,000	217,000	277,000	2,341,000	530,000	706,000	1,190,000	2,373,000	172,000	345,000	750,000	672,000	243,000	172,000	318,000	966,000	1,051,000	3,415,000	2,081,000	544,000
customer deposits and deferred revenue								-17,977,000	23,514,000	5,534,000	4,938,000	47,725,000	12,667,000	-1,243,000	2,433,000	-9,866,000	1,662,000	1,672,000	-4,304,000	13,258,000	8,712,000	-5,242,000	-11,161,000	-17,999,000	15,149,000	-3,855,000	8,293,000				1,317,000				5,239,000						17,610,000	13,989,000
repayment of 2023 notes										-20,173,000
proceeds from issuance of 2027 notes, net of issuance costs																				0
purchase of capped calls																			0	0
repurchase of 2023 notes																			0	0
inventories and deferred cost of sales															76,000	-6,581,000	-7,824,000	-10,474,000	-1,192,000	-5,816,000	-6,966,000	2,446,000	-2,952,000	9,387,000	45,000	8,489,000	-6,930,000			4,555,000	-3,150,000	-11,010,000	6,735,000	13,761,000				1,274,000
net transfer of property, plant and equipment to inventory															-190,000				0	1,098,000	0	526,000				130,000
proceeds from issuance of 2025 notes and 2027 notes, net of issuance costs
non-cash operating and financing activities
acquisitions of businesses, net of cash acquired																											0
purchases of common stock																											0
long-term income tax liability
proceeds from held for sale assets																							0								0
proceeds from long-term debt borrowings																															0	1,000	-1,000	335,752,000
principal payments on long-term debt
cash withholdings for employee stock purchase plan																								825,000	763,000	1,021,000
taxes paid for restricted stock vestings
gain on cumulative translation adjustment
net transfer of inventory to property, plant, and equipment
cash withholdings for employee stock purchase plans																														1,136,000
net transfer of property, plant, and equipment to (from) inventory																														339,000
gain on sale of lab tools
accounts receivable																																		6,495,000					-2,769,000								13,749,000	6,996,000	-1,905,000	20,004,000	34,479,000	-5,072,000	5,079,000	12,409,000	-32,075,000	55,888,000					6,174,000	20,709,000	3,349,000	1,372,000	1,942,000	-1,156,000	15,329,000	5,799,000	658,000	444,000	-8,837,000	11,496,000			-5,127,000	11,408,000
net increase in cash and cash equivalents																																		146,217,000	3,426,000				-64,882,000	20,261,000	10,730,000	32,312,000	6,803,000	31,676,000	17,650,000	3,883,000					70,001,000	41,715,000	57,410,000			31,705,000	-83,149,000	167,335,000	45,458,000
cash and cash equivalents - beginning of period																															0	0	0	277,444,000	0	0	0	269,232,000	0	0	0	270,811,000
cash and cash equivalents - end of period																																	-218,097,000	423,661,000	3,426,000	16,377,000	13,919,000	243,722,000	-64,882,000	20,261,000	10,730,000	303,123,000
proceeds (tax withholdings) from stock option exercises and employee stock purchase plan																																	913,000	585,000
provision (recovery) for bad debts
payments for purchases of cost method investment
proceeds from sale of property, plant, and equipment																																																															5,000	97,000	2,000
proceeds from sale of lab tools																																							420,000	1,115,000	120,000	1,413,000	2,225,000	0	4,694,000	2,340,000
proceeds from stock option exercises and employee stock purchase plan
repayments of long-term debt
net cash from (used) in financing activities
proceeds from sale of building
proceeds from stock option exercises																																				0			889,000	187,000	1,112,000	45,000	2,571,000	360,000	809,000	8,316,000	1,886,000	0	33,000	280,000	3,209,000	1,624,000	537,000	880,000	6,144,000	2,951,000	2,947,000	6,145,000	26,968,000
proceeds from employee stock purchase plan
proceeds from the liquidation of investments																																					67,215,000	10,930,000
proceeds (tax withholdings) from stock option exercises
inventory and deferred cost of sales
payment for purchase of cost method investment
reconciling adjustments:
proceeds from the liquidation of short-term investments																																								18,500,000	6,591,000	43,556,000		94,817,000	89,203,000	32,030,000
payments for purchases of short-term investments
taxes paid related to net share settlement of equity awards
effect of exchange rate changes on cash flows
supplemental information:
provision of bad debts
payments of tax withholdings - restricted shares
adjustments to reconcile net income to net cash from operating activities :
excess tax benefits from share-based compensation
impairment of long-lived assets
gain on disposal of segment
changes in operating assets and liabilities :
discontinued operations
payments for purchase of cost method investment
proceeds from sale of assets from discontinued segment																																																			0
excess tax benefits from equity-based compensation
cash and cash equivalents as of beginning of period																																											0	0	0	210,799,000				384,557,000
cash and cash equivalents as of end of period																																											6,803,000	31,676,000	17,650,000	214,682,000				223,121,000
non-cash asset impairment
non-cash equity-based compensation																																												4,490,000	5,091,000	4,722,000	4,076,000	2,762,000	3,713,000	2,579,000	3,485,000	4,014,000	3,130,000	2,311,000	4,063,000	3,098,000	1,875,000	2,958,000	2,170,000
provision (recovery) for bad debt
gross profit from sales of lab tools
accounts payable																																															5,235,000	-18,605,000	14,454,000	6,458,000				-15,254,000	21,270,000	6,478,000	-1,902,000	15,120,000	6,690,000						1,262,000				4,130,000	-1,740,000	4,004,000	2,761,000	-1,589,000	4,689,000			6,647,000	3,629,000	5,486,000
accrued expenses, customer deposits, deferred revenue and other current liabilities																																												11,992,000	18,030,000	11,608,000
income taxes payable																																												45,000
non-cash investing and financing activities
settlement of stock option exercise
benefit from bad debt																																																		16,000
restricted cash																																														1,974,000
amortization of debt discount																																																						0	491,000	769,000	768,000	760,000	741,000	714,000	707,000	693,000
excess tax benefits from stock option exercises																																																24,000	430,000	31,000	1,233,000	887,000	91,000	1,347,000	5,066,000	2,188,000
non-cash items from discontinued operations
income taxes receivable
transfers to restricted cash
payments for net assets of businesses acquired
transfers from (to) restricted cash related to discontinued operations
proceeds from short-term investments
proceeds from the sale of lab tools
purchases of treasury stock
cash and cash equivalents as of beginning of year
cash and cash equivalents as of end of year
accrual of fair value of contingent consideration
merger consideration adjustment
accrued expenses, deferred revenue and other current liabilities																																																		1,764,000
proceeds from liquidations of short-term investments
cash and cash equivalents at beginning of period																																																0			0						-89,000	0	148,589,000	0	0	103,799,000	0	0	117,083,000	0	0	147,046,000		0	0	124,499,000		0	0	100,276,000	0	0	106,830,000	214,295,000	63,420,000
cash and cash equivalents at end of period																																																6,118,000			70,001,000						-83,238,000	167,335,000	194,047,000	11,947,000	4,446,000	93,048,000	8,040,000	-4,785,000	114,429,000	323,000	13,510,000	94,569,000		10,536,000	2,490,000	113,539,000		2,347,000	8,680,000	100,676,000	-6,434,000	5,584,000	111,831,000	208,561,000	55,160,000
transfers from property, plant and equipment to inventory																																																0	2,089,000	135,000							-9,000	0	1,123,000
transfers from inventory to property, plant and equipment																																																0									0	0	850,000
adjustments to reconcile net income to net cash from operating
proceeds from sales of short-term investments																																																	171,213,000	101,236,000	76,770,000	55,964,000	43,569,000	292,990,000	252,078,000	122,148,000
transfers from restricted cash
operating activities
supplier deposits
accrued expenses, deferred profit and other current liabilities																																																									68,897,000	54,877,000	15,173,000										-2,931,000				-760,000				-7,603,000	14,124,000	4,022,000
investing activities
transfers (to) from restricted cash
financing activities
cash and cash equivalents at beginning of year																																																					217,922,000	0	0	245,132,000
cash and cash equivalents at end of year																																																					275,332,000	15,568,000	-79,169,000	276,837,000
non-cash restructuring
transfers from (to) restricted cash
proceeds from the maturity of cdars
sale of property, plant and equipment with note receivable																																																									0	0	140,000
non-cash inventory write-off																																																												0	0	1,526,000
non-cash cash flows from discontinued operations
cash flows from discontinued operations
payments of earn-outs for businesses acquired
proceeds from the sale of property, plant and equipment																																																									0	0	13,000
accrual of payment for net assets of businesses acquired
non-cash asset impairment charge																																																												0			0	0	285,000
proceeds from the redemption of short-term investments																																																										120,116,000	40,025,000
net income attributable to veeco																																																												1,270,000	-14,680,000	-20,902,000
non-cash share-based compensation																																																												2,400,000
non-cash restructuring charge
accrued expenses, deferred profit, and other current liabilities
payments for net assets of businesses acquired, net of cash acquired
payments for earn-outs of businesses acquired
proceeds from stock issuances																																																															12,000	514,000	155,000															45,000
accrual of payments for net assets of businesses acquired
transfers from property, plant, and equipment to inventory																																																												918,000	-119,000	360,000	19,000	22,000	363,000
transfers from inventory to property, plant, and equipment																																																												0	0	23,000
payment of earn-outs for businesses acquired
net decrease in cash and cash equivalents
accrual of payment for net assets acquired
non-cash share-based compensation expense																																																														1,398,000
payment of earn-out for solar business
net gain on extinguishment of long-term debt
non-cash compensation expense for stock options and restricted stock																																																															2,048,000	2,014,000	1,609,000
noncontrolling interest
gain on sale of property, plant, and equipment
bad debt expense
payments for net assets of business acquired, net of cash acquired
payments for debt issuance costs
net change in cash and cash equivalents																																																																										2,347,000	8,680,000	400,000	-6,434,000	5,584,000	5,001,000
accrual of earn-out payments for business acquired
exchange of convertible subordinated notes
net gain on early extinguishment of long-term debt
gain on extinguishment of debt
non-cash compensation expense for share-based payments																																																																		1,444,000	1,257,000	789,000
noncontrolling interest in net income of subsidiary
gain on sale of property, plant and equipment
write-off of purchased in-process technology																																																																					0
proceeds from sale of property, plant and equipment																																																																		7,000	75,000	229,000									0
net maturities of investments
proceeds from stock issuance																																																																		650,000	1,573,000	558,000		7,099,000	5,875,000	2,108,000		779,000	914,000	127,000	143,000	836,000	2,038,000		3,002,000
effect of exchange rates on cash and cash equivalents																																																																										241,000	880,000	692,000		-404,000	705,000		1,656,000
supplemental disclosure of non-cash investing and financing activities
acquisition of assets in connection with the consolidation of a variable interest entity
assumption of liabilities in connection with the consolidation of a variable interest entity
gain on sale of property plant and equipment
net purchases of investments
net (gain) loss on sale of fixed assets
non-cash merger and restructuring expenses
changes in operating assets and liabilities, net of effect of acquisitions:
proceeds from sale of property, plant and equipment and assets held for sale																																																																					12,000	0	25,000	10,000	0	82,000
purchase of long-term investments
maturities of long-term investments
(gain) loss on sale of property plant and equipment
compensation expense for share-based payments
compensation expense for stock options and restricted stock																																																																								189,000
stock option income tax benefit
net gain on sale of fixed assets
repayments of long-term debt and borrowings under lines of credit
loss on sale of property, plant and equipment
non-cash compensation expense
payment for net assets of businesses acquired
net (purchases) maturities of long-term investments
repayment of long-term debt
net maturities of long-term investments																																																																													-51,000
proceeds from sale of fixed assets																																																																												5,000			26,000
proceeds from sale of assets held for sale																																																																												2,173,000	0
net purchase of long-term investments
net assets of business acquired
loss on disposal of discontinued operations
proceeds from sale of industrial measurement business
proceeds from issuance of long-term debt
payment for debt issuance costs
proceeds from the sale of assets held for sale																																																																																1,118,000
net purchases of long-term investments
net sales/(purchases) of short-term investments																																																																																	26,896,000
proceeds from sale of business
net proceeds from borrowings under line of credit																																																																																	25,000,000
financing activities three months ended 12/31/99 – cvc

We provide you with 20 years of cash flow statements for Veeco Instruments stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Veeco Instruments stock. Explore the full financial landscape of Veeco Instruments stock with our expertly curated income statements.

The information provided in this report about Veeco Instruments stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.